News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

International Medical Technology Investors Convening at Elsevier Business Intelligence's 'Investment in Innovation (IN3) Medical Device 360° London' Event in 2 Weeks: April 25-26, 2012


4/9/2012 8:52:54 AM

LONDON--(Marketwire - April 09, 2012) - Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, will host an outstanding program of top-tier international device investors, business development decision-makers and innovative start-ups at its 'IN3 Medical Device 360° London' investment and partnering conference on April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre, London Kensington.

The conference will feature an outstanding agenda of panels and networking sessions covering critical issues facing the global device industry in 2012 and beyond. Participating speakers include: Edward Andrle, VP, Business Development & Strategy, Sorin Group; Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips Healthcare; Aris Constantinides, Investment Director, NBGI Ventures; Bulend Corbacioglu, VP, Business Development and Licensing, Covidien; Townsend Goddard, Director, Business Development & Strategic Planning, Stryker; Victor Higgs, Managing Director, Applied Nanodetectors; William McKeon, CEO, Cellnovo; Alan O'Connell, Partner, Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Stan Rabinovich, VP, Advanced Technology, Edwards LifeSciences; and Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director, ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Rainbow Medical, Wellington Partners, Delta Partners, Peppermint VIP, and Family Office Fund. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

'IN3 Medical Device 360° London' also will feature presentations by approximately two dozen early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. Presenting companies to date include: AiMedics, Anethon, CellCoTec, Cortical Dynamics, Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products, N8 Medical, NUUBO, QSTREAM VASCULAR, Replication Medical, Sapiens Steering Brain Stimulation, Sensible Medical Innovations, Soft Tissue Regeneration, Specialty Scanners, Vantix, and Vascular Flow Technologies.

This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

IN3 Medical Device 360° London will be held at the Millennium Gloucester Hotel & Conference Centre, London Kensington. Event co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.


Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES